Summary
Updated Aug 31, 2026
Kush Parmar is Director of Entrada Therapeutics, Inc. (TRDA). 6 SEC Form 4 filings on record going back to 2025, most recently on 10 August 2026. Most recent open-market trade: sold $647K of TRDA on 10 August 2026. Lifetime open-market sales: $4.72M.
Recent Transactions
14Every recent SEC Form 4 transaction Kush Parmar has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Kush Parmar go back to 2025: 6 primary Form 4 filings, an average of 3.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Kush Parmar files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- 5AM Ventures V, L.P. - $3.00M of TRDA open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $1.61M of TRDA open-market activity in the last 12 months
- MPM BIOVENTURES 2018, L.P. - $462K of TRDA open-market activity in the last 12 months
- MPM BioVentures 2014, L.P. - $462K of TRDA open-market activity in the last 12 months
- Kory James Wentworth - $434K of TRDA open-market activity in the last 12 months
- Nathan J. Dowden - $426K of TRDA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Kush Parmar?
Kush Parmar is a corporate insider, tracked as Director of Entrada Therapeutics, Inc. (TRDA). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kush Parmar submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Kush Parmar been buying or selling stock?
Recorded transactions: 0 open-market purchases and 14 open-market sales ($4.72M) across all tracked filings.
Where can I see all of Kush Parmar's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Kush Parmar and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial